VivoSim Labs (VIVS) Receivables - Other (2020 - 2025)
VivoSim Labs (VIVS) posted Receivables - Other of $1.0 million for Q3 2025, little changed on a QoQ basis from $1.0 million in Q2 2025.
Powered by 
Analysis
VivoSim Labs (VIVS) Receivables - Other (2020 - 2025) Analysis & Trends
VivoSim Labs has reported Receivables - Other for 2 years, with the latest figure at $1.0 million in Q3 2025.
- On a quarterly basis, Receivables - Other changed N/A year-over-year to $1.0 million in Q3 2025; TTM through Sep 2025 was $1.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.0 million, changed N/A from the prior year.
- Receivables - Other was $1.0 million for Q3 2025 at VivoSim Labs, roughly flat from $1.0 million in the prior quarter.
- The five-year high for Receivables - Other was $1.0 million in Q3 2025, with the low at $1.0 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Jun 30, 2020 | 28,000.00 |